Montreal Heart Institute reports positive results from Covid-19 trial
The Montreal Heart Institute (MHI) has announced positive, clinically persuasive results from the COLCORONA clinical trial of orally administered drug, colchicine, for treating Covid-19.
Phase II Trial of Anti-Amyloid AR1001 Signals Little Promise for Patients with Alzheimer’s Disease
On January 21, AriBio, a biopharmaceutical company based in South Korea, announced the completion of a Phase II clinical trial of AR1001, an oral biological therapy for the potential treatment…